Dynamic Technology Lab’s Harmony Biosciences HRMY Stock Holding History

Dynamic Technology Lab’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,430	Closed	-$404K	–	857
2026 Q1	$404K	Buy	+14,430	New	+$473K	0.07%	520
2024 Q1	–	Sell	-13,360	Closed	-$432K	–	1218
2023 Q4	$432K	Buy	+13,360	New	+$373K	0.05%	650
2023 Q2	–	Sell	-9,246	Closed	-$302K	–	1167
2023 Q1	$302K	Sell	9,246 -4,154	-31%	-$189K	0.03%	792
2022 Q4	$738K	Buy	+13,400	New	+$737K	0.07%	439
2022 Q3	–	Sell	-7,610	Closed	-$371K	–	1301
2022 Q2	$371K	Sell	7,610 -2,020	-21%	-$90.9K	0.04%	695
2022 Q1	$468K	Buy	9,630 +730	+8%	+$29.8K	0.06%	609
2021 Q4	$379K	Buy	8,900 +700	+9%	+$27.9K	0.04%	717
2021 Q3	$314K	Buy	+8,200	New	+$264K	0.04%	729

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dynamic Technology Lab's HRMY Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 14,430 shares — an estimated $404K sold.

Dynamic Technology Lab first reported a position in HRMY in Q3 2021 and held it in 8 quarters. The position peaked at $738K in Q4 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Dynamic Technology Lab reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
Dynamic Technology Lab sold 14,430 Harmony Biosciences shares in Q2 2026, an estimated $404K.
Dynamic Technology Lab first reported a position in Harmony Biosciences in Q3 2021 and held it in 8 quarters.
Dynamic Technology Lab's Harmony Biosciences position peaked at $738K in Q4 2022.
328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.